Personalized Medicine In 2010: Welcome To The Establishment
By
Mark Ratner / Email the Author / IN VIVO January 2011, Vol. 29, No. 1
Feature Articles / Word Count: 1962 / Article # 2011800006
Executive Summary
Evidence of progress for molecular diagnostics and instrumentation, the mainstays of the personalized medicine toolkit, was considerable in 2010. Much of the activity centered on sequencing, although its general utility in clinical diagnostics has not yet been demonstrated and whether measurements of gene expression can form the basis for a plethora of molecular tests also remains an open question. In abbreviated form, we list some of the important dealmaking activities and trends of the year.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.